1,205
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines

Protective doses of tetanus toxoid immunization and its associated factors among mothers in southern Ethiopia

, &
Article: 2320501 | Received 19 Oct 2023, Accepted 15 Feb 2024, Published online: 11 Mar 2024

References

  • Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, Iskander JK, Brown K, Moran JS. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2008;57(RR–4):1–9. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=351756224.
  • Bourget CBD. Tetanus. Natl Libr Med [Internet]. 2023. https://www.ncbi.nlm.nih.gov/books/NBK459217/.
  • European center for disease prevention and control (ECDC). Congenital toxoplasmosis annual epidemiological report for 2018 key facts. 2021 Dec.
  • World Health Organization. Protecting all against tetanus [Internet]. 2017;92:1–6. https://www.who.int/publications/i/item/protecting-all-against-tetanus.
  • Sheffield JS, Ramin SM. Tetanus in pregnancy. Am J Perinatol. 2004;21(4):173–182. doi:10.1055/s-2004-828605.
  • WHO. Safety of immunization during pregnancy a review of the evidence. WHO [Internet]; 2014. p. 1–22. www.who.int/vaccine_safety/…/safety_pregnancy_nov2014.pdf.
  • Vouking MZ, Tadenfok CN, Ekani JME. Strategies to increase immunization coverage of tetanus vaccine among women in Sub Saharan Africa: a systematic review. Pan Afr Med J. 2017;27(Supp 3):25. doi:10.11604/pamj.supp.2017.27.3.11535.
  • Messeret ES, Masresha B, Yakubu A, Daniel F. Europe PMC funders group maternal and neonatal tetanus elimination (MNTE) in the WHO African region. J Immunol Sci. 2019;2:103–107. doi:10.29245/2578-3009/2018/si.1115.
  • Farag RS, Abdel Latif MS, Abd El-Gawad AE, Dogheim SM. Monitoring of pesticide residues in some Egyptian herbs, fruits and vegetables. Int Food Res J. 2011;18:659–665.
  • Nass SS. A pilot study. Heal Serv Res Manag Epidemiol. 2018;5:233339281878958. doi:10.1177/2333392818789585.
  • World Health Organization (WHO). Global vaccine action plan. Vaccine. 2013;31:B5–31. doi:10.1016/j.vaccine.2013.02.015.
  • WHO. Immunization agenda 2030. 2022. p. 1–58. https://www.who.int/immunization/ia2030_Draft_One_English.pdf?ua=1.
  • Belay AT, Fenta SM, Agegn SB, Muluneh MW, Ortega JA. Prevalence and risk factors associated with rural women’s protected against tetanus in East Africa: evidence from demographic and health surveys of ten East African countries. PLoS One. 2022;17(3):e0265906. doi:10.1371/journal.pone.0265906.
  • Nigussie J, Girma B, Molla A, Mareg M. Tetanus toxoid vaccination coverage and associated factors among childbearing women in Ethiopia: a systematic review and meta-analysis. Biomed Res Int. 2021;2021:5529315. doi:10.1155/2021/5529315.
  • Omer S, Mohamed O, Ahmed EM. Prevalence and determinants of antenatal tetanus vaccination in Sudan: a cross – sectional analysis of the multiple indicator cluster survey. Trop Med Health. 2022;50. doi:10.1186/s41182-022-00398-4.
  • Mengesha MB, Weldegeorges DA, Assefa NE, Gebremeskel SG, Hidru HD, Teame H, Hailesilassie Y. Tetanus toxoid immunization status and Associated Factors among mothers in Hawzen, eastern zone of Tigray, Ethiopia, 2019. Open Public Health J. 2020;13(1):281–288. doi:10.2174/1874944502013010281.
  • Gebremedhin TS, Welay FT, Mengesha MB, Assefa NE, Werid WM. Tetanus toxoid vaccination uptake and associated factors among mothers who gave birth in the last 12 Months in Errer District, Somali regional state, Eastern Ethiopia. Biomed Res Int. 2020;2020:4023031. doi:10.1155/2020/4023031.
  • Gessesse DN, Yismaw AE, Yismaw YE, Workneh TW. Coverage and determinants of protective dose tetanus toxoid vaccine among postnatal women delivered at university of Gondar comprehensive specialized hospital, northwest Ethiopia, 2019. Clin Epidemiol Glob Heal. 2021;12(June):100814. doi:10.1016/j.cegh.2021.100814.
  • Faria APV, da Silva TPR, Vieira EWR, Lachtim SAF, Rezende EM, Matozinhos FP. Factors associated with tetanus vaccination in pregnant women living in Minas Gerais State, Brazil: a cross-sectional study. Public Heal Pract. 2021;2(August):100203. doi:10.1016/j.puhip.2021.100203.
  • Hasnain S, Sheikh N. Causes of low tetanus vaccination coverage in pregnant women in Lahore district, Pakistan. Eastern Mediterranean Health Journal; 2007.
  • Ethiopian Federal ministry of health. Ethiopian national expanded program on immunization comprehensive multi-year plan. 2015. p. 1–104.
  • Adugna E. Factors influencing tetanus toxoid immunization and protection at birth coverage among child breang age women of ambo town and its surrounding area, Oromia regional state, Ethiopia; 2011. p. 1–13.
  • Mamoro MD, Hanfore LK. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro Zone, SNNP, Ethiopia. J Nutr Metab. 2018;2018:1–9. doi:10.1155/2018/2839579.
  • Diamenu SK. Introducing protection at birth (Pab) method of monitoring Tetanus-Diphtheria (Td) vaccination coverage of mothers in Ghana. Int J Vaccines Immun. 2015;1(1):1–4. doi:10.16966/2470-9948.102.
  • Mihret MS, Limenih MA, Gudayu TW. The role of timely initiation of antenatal care on protective dose tetanus toxoid immunization: the case of northern Ethiopia post natal mothers. BMC Pregnancy Childbirth. 2018;18(1):1. doi:10.1186/s12884-018-1878-y.
  • States M, Strategic WHO, Group A, Grade T, Sage T. Tetanus vaccines: WHO position paper – February 2017. Relev Epidemiol Hebd. 2017;92:53–76.
  • Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int Health Hum Rights. 2018 Jun;18(1). doi:10.1186/s12914-018-0168-0.
  • Amin MB, Roy N, Meem AE, Hossain E, Aktarujjaman M. Trends and determinants of taking tetanus toxoid vaccine among women during last pregnancy in Bangladesh: Country representative survey from 2006 to 2019. PLoS One. 2022;17(10):e0276417. doi:10.1371/journal.pone.0276417.
  • Jamil NF, Salih AA, Sadiq MA, Ibrahim-Moh M. Tetanus toxoid vaccination status of women in Baghdad. Saudi J Med. 2022;3389:264–271. doi:10.36348/sjm.2022.v07i05.004.
  • Gessesse DN, Yismaw AE, Yismaw YE, Workneh TW. Coverage and determinants of protective dose tetanus toxoid vaccine among postnatal women delivered at university of Gondar comprehensive specialized hospital, northwest Ethiopia, 2019. Clin Epidemiol Glob Heal. 2021;12(June):100814. doi:10.1016/j.cegh.2021.100814.
  • Barrow A, Barrow S, Jobe A. Differentials in prevalence and correlates on uptake of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy: a community-based cross- sectional study in the Gambia. SAGE Open Med. 2022;10(1):205031212110659. doi:10.1177/20503121211065908.